Summary
Cencora, Inc. (formerly AmerisourceBergen Corporation) announced on March 24, 2014, a significant strategic move into the Brazilian pharmaceutical market. The company has entered into a definitive agreement to acquire a minority stake in Profarma Distribuidora de Produtos Farmacêuticos S.A., a prominent pharmaceutical wholesaler in Brazil. This acquisition, coupled with the establishment of a joint venture for specialty distribution and services with Profarma, signals Cencora's intent to expand its international footprint and leverage growth opportunities in key emerging markets. Investors should note the total expected investment of approximately $100 million for this transaction, which is anticipated to close in the June quarter of fiscal year 2014. Importantly, Cencora anticipates that this acquisition will not have a material impact on its adjusted earnings per share from continuing operations for fiscal year 2014, suggesting a long-term strategic investment rather than an immediate earnings driver.
Key Highlights
- 1Cencora (formerly AmerisourceBergen) to acquire a minority stake in Profarma, a leading Brazilian pharmaceutical wholesaler.
- 2Establishment of a joint venture with Profarma focused on specialty distribution and services.
- 3Total expected investment in the transaction is approximately $100 million.
- 4Transaction expected to close in the June quarter of fiscal year 2014.
- 5No meaningful impact expected on fiscal year 2014 adjusted EPS from continuing operations.
- 6This move represents an expansion into the Brazilian pharmaceutical market.